Rapport Therapeutics IPO

Rapport Therapeutics is dedicated to crafting precision medicines tailored to the complexity of the human brain, marking a significant stride in the field of neuro medicines. Emphasizing a scientific partnership approach, they deliver revolutionary, relentless, and precise treatments. Their mission is to address neurological complexities with unmatched accuracy, leveraging cutting-edge research and development to create therapies that accurately match the nuanced needs of individuals. ​​

Register for Details

For more details on financing and valuation for Rapport Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Rapport Therapeutics

Forge green plus iconForge green minus icon

What is Rapport Therapeutics's IPO price?

The IPO price for Rapport Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Rapport Therapeutics?

Rapport Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Rapport Therapeutics shares pre-IPO?

If you own Rapport Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Rapport Therapeutics a publicly traded company?

Rapport Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Rapport Therapeutics's funding to date?

Rapport Therapeutics has raised $250.18MM to date.
Forge green plus iconForge green minus icon

When was Rapport Therapeutics founded?

Rapport Therapeutics was founded in 2022.

Rapport Therapeutics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
8/7/2023 Series B $150MM raised $XXX.XX $XXX.XX
3/7/2023 Series A $100.18MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 15, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.